Cargando…
Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
Identifying the causes of high fever syndromes such as Kawasaki disease (KD) remains challenging. To investigate pathogen exposure signatures in suspected pathogen-mediated diseases such as KD, we performed immunoglobulin (Ig) profiling using a next-generation sequencing method. After intravenous Ig...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048982/ https://www.ncbi.nlm.nih.gov/pubmed/29771320 http://dx.doi.org/10.1093/hmg/ddy176 |
_version_ | 1783340201325625344 |
---|---|
author | Ko, Tai-Ming Kiyotani, Kazuma Chang, Jeng-Sheng Park, Jae-Hyun Yin Yew, Poh Chen, Yuan-Tsong Wu, Jer-Yuarn Nakamura, Yusuke |
author_facet | Ko, Tai-Ming Kiyotani, Kazuma Chang, Jeng-Sheng Park, Jae-Hyun Yin Yew, Poh Chen, Yuan-Tsong Wu, Jer-Yuarn Nakamura, Yusuke |
author_sort | Ko, Tai-Ming |
collection | PubMed |
description | Identifying the causes of high fever syndromes such as Kawasaki disease (KD) remains challenging. To investigate pathogen exposure signatures in suspected pathogen-mediated diseases such as KD, we performed immunoglobulin (Ig) profiling using a next-generation sequencing method. After intravenous Ig (IVIG) treatment, we observed disappearance of clonally expanded IgM clonotypes, which were dominantly observed in acute-phase patients. The complementary-determining region 3 (CDR3) sequences of dominant IgM clonotypes in acute-phase patients were commonly observed in other Ig isotypes. In acute-phase KD patients, we identified 32 unique IgM CDR3 clonotypes shared in three or more cases. Furthermore, before the IVIG treatment, the sums of dominant IgM clonotypes in IVIG-resistant KD patients were significantly higher than those of IVIG-sensitive KD patients. Collectively, we demonstrate a novel approach for identifying certain Ig clonotypes for potentially interacting with pathogens involved in KD; this approach could be applied for a wide variety of fever-causing diseases of unknown origin. |
format | Online Article Text |
id | pubmed-6048982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60489822018-07-20 Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment Ko, Tai-Ming Kiyotani, Kazuma Chang, Jeng-Sheng Park, Jae-Hyun Yin Yew, Poh Chen, Yuan-Tsong Wu, Jer-Yuarn Nakamura, Yusuke Hum Mol Genet Articles Identifying the causes of high fever syndromes such as Kawasaki disease (KD) remains challenging. To investigate pathogen exposure signatures in suspected pathogen-mediated diseases such as KD, we performed immunoglobulin (Ig) profiling using a next-generation sequencing method. After intravenous Ig (IVIG) treatment, we observed disappearance of clonally expanded IgM clonotypes, which were dominantly observed in acute-phase patients. The complementary-determining region 3 (CDR3) sequences of dominant IgM clonotypes in acute-phase patients were commonly observed in other Ig isotypes. In acute-phase KD patients, we identified 32 unique IgM CDR3 clonotypes shared in three or more cases. Furthermore, before the IVIG treatment, the sums of dominant IgM clonotypes in IVIG-resistant KD patients were significantly higher than those of IVIG-sensitive KD patients. Collectively, we demonstrate a novel approach for identifying certain Ig clonotypes for potentially interacting with pathogens involved in KD; this approach could be applied for a wide variety of fever-causing diseases of unknown origin. Oxford University Press 2018-08-01 2018-05-16 /pmc/articles/PMC6048982/ /pubmed/29771320 http://dx.doi.org/10.1093/hmg/ddy176 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Articles Ko, Tai-Ming Kiyotani, Kazuma Chang, Jeng-Sheng Park, Jae-Hyun Yin Yew, Poh Chen, Yuan-Tsong Wu, Jer-Yuarn Nakamura, Yusuke Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment |
title | Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment |
title_full | Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment |
title_fullStr | Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment |
title_full_unstemmed | Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment |
title_short | Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment |
title_sort | immunoglobulin profiling identifies unique signatures in patients with kawasaki disease during intravenous immunoglobulin treatment |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048982/ https://www.ncbi.nlm.nih.gov/pubmed/29771320 http://dx.doi.org/10.1093/hmg/ddy176 |
work_keys_str_mv | AT kotaiming immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment AT kiyotanikazuma immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment AT changjengsheng immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment AT parkjaehyun immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment AT yinyewpoh immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment AT chenyuantsong immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment AT wujeryuarn immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment AT nakamurayusuke immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment |